329 related articles for article (PubMed ID: 19272726)
1. Imaging in multiple myeloma.
Delorme S; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
[TBL] [Abstract][Full Text] [Related]
2. Imaging in multiple myeloma.
Delorme S; Baur-Melnyk A
Recent Results Cancer Res; 2011; 183():133-47. PubMed ID: 21509684
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
4. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.
Hanrahan CJ; Christensen CR; Crim JR
Radiographics; 2010 Jan; 30(1):127-42. PubMed ID: 20083590
[TBL] [Abstract][Full Text] [Related]
5. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
Wiesenthal AA; Nguyen BD
Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
[TBL] [Abstract][Full Text] [Related]
6. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
7. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
8. Modern imaging of multiple myeloma.
Seppanen M
Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
[No Abstract] [Full Text] [Related]
9. Myeloma update.
Mulligan ME
Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
[TBL] [Abstract][Full Text] [Related]
10. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
Durie BG
Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
[TBL] [Abstract][Full Text] [Related]
11. Imaging patients with myeloma.
Winterbottom AP; Shaw AS
Clin Radiol; 2009 Jan; 64(1):1-11. PubMed ID: 19070692
[TBL] [Abstract][Full Text] [Related]
12. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic tumors and metastases involving bone.
Kim SH; Smith SE; Mulligan ME
Radiol Clin North Am; 2011 Nov; 49(6):1163-83, vi. PubMed ID: 22024293
[TBL] [Abstract][Full Text] [Related]
14. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
16. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
17. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
Zamagni E; Nanni C; Patriarca F; Englaro E; Castellucci P; Geatti O; Tosi P; Tacchetti P; Cangini D; Perrone G; Ceccolini M; Brioli A; Buttignol S; Fanin R; Salizzoni E; Baccarani M; Fanti S; Cavo M
Haematologica; 2007 Jan; 92(1):50-5. PubMed ID: 17229635
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
Tewfik JN; Greene GS
Curr Probl Diagn Radiol; 2008; 37(4):178-88. PubMed ID: 18502325
[TBL] [Abstract][Full Text] [Related]
19. Focal bone marrow involvement in multicentric castleman disease demonstrated by FDG PET/CT.
Ramos CD; Massumoto CM; Rosa MF; Mazo-Ruiz MF; Mitteldorf C; Etchebehere EC; Santos AO; Lima MC; Cerri GG; Camargo EE
Clin Nucl Med; 2007 Apr; 32(4):295-6. PubMed ID: 17413577
[No Abstract] [Full Text] [Related]
20. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
Chong EA; Torigian DA; Mato AR; Downs LH; Schuster SJ
Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
[No Abstract] [Full Text] [Related]
[Next] [New Search]
